Protalix BioTherapeutics
PLX
#8264
Rank
C$0.28 B
Marketcap
$3.81
Share price
1.13%
Change (1 day)
86.38%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -C$10.4 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$45.66 Million. In 2023 the company made an earning of C$16.66 Million, an increase over its 2022 earnings that were of -C$16.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$10.4 Million-162.34%
2023 C$16.66 M-199.05%
2022 -C$16.83 Million-40.38%
2021 -C$28.23 Million-732.31%
2020 C$4.46 M-130.53%
2019 -C$14.63 Million189.85%
2018 -C$5.05 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$26.26 Million-32.37%
2015 -C$38.82 Million10.11%
2014 -C$35.26 Million-7.59%
2013 -C$38.15 Million
2011 -C$44.18 Million-19.39%
2010 -C$54.8 Million20.87%
2009 -C$45.34 Million32.26%
2008 -C$34.28 Million-5.46%
2007 -C$36.26 Million
2004 -C$0.24 Million12.35%
2003 -C$0.21 Million-11.1%
2002 -C$0.24 Million-57.03%
2001 -C$0.55 Million1.03%
2000 -C$0.55 Million-53.22%
1999 -C$1.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$96.93 Million 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.93 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.84 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.59 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel